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Thyroid hormones acutely regulate gene expression of the b-catalytic subumt of the mitochondrtal F,-ATPase complex in the liver of hypothyroid 
rat neonates at either a transcriptional and/or post-transcriptional level [(1990) J. Biol. Chem. 26.5. 9090-90971. Admmistration at berth of various 
thyroid hormone doses to hypothyrotd newborn rats promote a rapid (1 h) increase m liver steady-state amounts of both j?-F,-ATPase protem 
and mRNA. Induction of the /?-F,-ATPase mRNA is coincident with an elevation in gene transcription detected using nascent RNA chains 
synthesized by isolated nuclei. These results suggest that thyroid hormones induction of postnatal mitochondrial differentiation in the liver of 
hypothyroid rat neonates IS mostly triggered by transcriptional regulatton of B-F,-ATPase gene. 
B-F,-ATPase transcrtption; Thyroid hormone; Mitochondrial differentiation: Newborn; Liver 
1. INTRODUCTION 
The rapid switch in metabolic pathways relevant for 
energy provision in the liver, from the predominant fetal 
anaerobic glycolysis [1,2] to the efficient neonatal oxida- 
tive phosphorylation [3,4], affords an excellent experi- 
mental system for the study of mammalian mitochon- 
drial biogenesis [4,5]. Mitochondrial biogenesis in rat 
liver has a postnatal onset and results from the opera- 
tion of two processes, proliferation and differentiation 
of the organelle [4,6], both resulting from a coordinated 
expression of the two genetic systems in which mito- 
chondrial proteins are encoded [7,8]. Mitochondrial 
proliferation in rat liver is a continuous process that 
spans the whole developmental period [6], while differ- 
entiation of the organelle, i.e., the acquisition of the 
ultrastructural, molecular and functional characteristics 
that define mitochondrial function, precisely takes place 
during the first hour following birth [3-51. It has been 
recently documented that regulation of the expression 
of nuclear-encoded proteins needed for mitochondrial 
differentiation is exerted at the translational level [9]. 
Furthermore, short- and long-term effects of thyroid 
hormones are known to affect mitochondrial functions, 
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number and molecular structure (for references see [5]). 
Modulation of gene expression through the control of 
DNA transcription is the first stage at the molecular 
level for induction of a specific gene by thyroid 
hormones [lo]. However, additional levels of regulation 
of gene expression have been reported to be modulated 
by thyroid hormones [ 1 l-l 51. Regulation of mitochon- 
drial biogenesis by thyroid hormones [16] has been 
shown to promote a coordinated up-regulation of all 
mitochondrial mRNAs [17] and a differential response 
in gene activation for those nuclear genes coding for 
mitochondrial proteins [18]. Recently, we have explored 
the role of thyroid hormones in rat liver postnatal mito- 
chondrial differentiation [5]. We used, as a marker pro- 
tein of mitochondrial biogenesis during this stage of 
development, the nuclear encoded /?-catalytic subunit of 
the mitochondrial F,-ATPase complex [5]. The results 
obtained indicate that thyroid hormones regulate the 
basal expression of /I-F,-ATPase gene at either a tran- 
scriptional and/or post-transcriptional level [5]. We re- 
port herein, using in vitro run-on assays of isolated liver 
nuclei from hypothyroid rat neonates treated at birth 
with various thyroid hormones doses, that the hormo- 
nal treatment affects transcriptional rates of the p-F,- 
ATPase gene, suggesting that nuclear transcription is 
the major site of thyroid hormone action on F,-ATPase 
gene expression for postnatal mitochondrial differentia- 
tion. 
Abbremattons. T4, 3,5,3’S’-tetraiodo-L-thyronine; T3. 3.5,3’-truodo- 
L-thyronine; TRE, thyroid hormone-responsive elements; MMI, l- 
methylimtdazole-2-thiol: SK, standard saline citrate; EDTA, ethyl- 
enediammetetraacetic acid; DTT, dtthiothrettol; SDS. sodmm dodecyl 
sulfate; PMSF, phenylmethylsulfonyl fluoride; PVDF, polyvinylidene 
difluortde. 
2. MATERIALS AND METHODS 
2.1 Anmuls and treutments 
Timed-pregnant albino Wistar rats weighing 200 g were housed 
under controlled conditions [3]. Maternal and fetal hypothyroidism 
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were induced by admmistration of 0.02% MM1 m the drinking water 
of pregnant rats from day 14 of gestation [5]. Term hypothyroid 
fetuses were delivered and maintamed at 37°C without feedmg as 
described [5]. At the time of delivery. hypothyroid newborns were 
inJected intraperitoneally with 50~1 of a 0.9% NaCl solution contam- 
ingO+O(Oxdose);45+166(1xdose)or45+166(10xdose) 
flg/lOO g body weight of T3 + T4, respectively. 
2.2. Nuclear transcnptlon assays 
Nuclei from 1 g of one hour-old hypothyrotd and (T3 + T4)-treated 
hypothyroid neonatal rat livers were prepared by centrifugation 
through a 2 M sucrose cushion as described in [19] and modified in 
[20]. Washed isolated nuclei were resuspended in 25% glycerol. 50 mM 
Tris-HCI; pH 8, 5 mM magnesium acetate. 0.1 mM PMSF. 0.1 mM 
EDTA and 5 mM DTT. Ahquots of diluted nuclei were (i) stained with 
4% Giemsa solution, visualized and counted under light microscopy 
and (ii) used for the determmation of AL60nm. A linear correlation 
(m = 0.33, b = 0.004, r = 0.976, n = 19. P < 0.001) between the num- 
ber of nuclei (O-9 x IOh) and A261,nm (O-3 O.D.) was obtained (not 
shown). Nuclei (20 x 106) were used in ‘run-on’ assays immediately 
after isolation. The transcription reaction was carried out m the pres- 
ence of 200 ,Ki of [3’P]UTP (3,000 Ci/mmol). RNase inhibitor 
(Boehringer Mannheim. 40 U/,1) and 0.5 mM each of ATP, CTP and 
GTP as described m [?l] The reaction was incubated at 25°C for 60 
min and terminated by addttion of 10 ~1 nbonuclease-free DNase I 
(Boehrmger Mannhelm, 23 U/pl~ and 10 ~1 of 20 mM CaCl:. Total 
nuclear RNA was isolated [22]. For specific detection of radioactive 
nascent RNA transcripts, 10 x IO” cpm of the isolated RNA was 
hybridized for 60 mm at 60°C and 72 h at 42°C with various plasmid 
DNAs tmmobilized on nylon filters (see Fig. 1). Undigested plasmid 
DNAs (10 p(g) were denatured with 3 M NaOH at 65°C for 60 min 
and neutralized with 2 M NH,Ac. pH 7. Denatured DNAs were 
applied to nylon membranes using a slot blot apparatus (Schleider and 
Schuell, Keene. NH. USA). After hybridization, membranes were 
washed according to the following protocol (i) 1 x SSC contammg 
0 1% SDS at 65°C for 15 min (2 times) and (ii) 0. I x SSC contammg 
0.1% SDS at 65’C for 10 min (1 time). Membranes were exposed to 
X-ray films and analyzed by densitometric scannmg 
2.3. Other methods 
Preparation of liver homogenates, ‘Western blot’ analysis of mtto- 
chondrial p subunit of the F,-ATPase complex, RNA isolation and 
nucleic acid hybridization of /?-F,-ATPase mRNA have been previ- 
ously reported m detail [5.9]. 
2.4. DNA probes 
Both a 1,577 and a 1,218 bp cDNA probe for rat liver [23] and D 
melanogaster P-F,-ATPase, generously provided by Dr. P.L. Pedersen 
(The John’s Hopkins University, Baltimore) and Dr R. Garesse 
(Umversidad Autonoma de Madrid. Spam). were used. The full-length 
human B-actin cDNA clone pHF5 [24] was kmdly provided by Dr. J. 
Ortin. Vector DNA (pUC18) [25] was included as a negative control 
for non-specific hybridization 
3. RESULTS AND DISCUSSION 
We have recently reported that administration of thy- 
roid hormones to hypothyroid neonates promote a 
rapid increase and similar response in magnitude in 
liver (i) mitochondrial ATPase activity, (ii) amount of 
P-F,-ATPase protein. (iii) steady-state P-F,-ATPase 
mRNA content and (iv) in vivo relative rates of P-F,- 
ATPase synthesis [5]. These provided evidence for a 
rapid thyroid hormone-mediated regulation of the nu- 
clear coded B-subunit of the mitochondrial /?-F,-ATP- 
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Fig. I. Effect of thyroid hormones on the induction of /J-F,-ATPase 
protein, mRNA content and on the transcriptional rate ofp-F,-ATP- 
ase gene in the hver of hypothyroid rat neonates. At the time of 
delivery. hypothyroid rat neonates were intraperttoneally injected with 
various T3 + T4 doses (0 x dose. 0 + 0. 1 x dose: 4.5 + 16.6 and 10 x 
dose: 45 + 166 fig/l00 g body weight of T3 + T4, respectively). 1 h 
after birth, newborns were decapitated and liver homogenates. total 
liver RNA and liver nuclei isolated as described m section 2 The rates 
of gene transcription were determined in nuclear run-on assays by the 
level of mcorporation of [a-“P]UTP mto nascent RNA transcripts 
after hybridization of 10 x 10’ cpm of isolated RNA to 10 pug of 
immobilized rat hver/?-F,-ATPase and human,f&actm cDNAs. Vector 
DNA (pUCl8) was mcluded as a negative control for non-spectfic 
hybridization. (A) Upper panel. Coomassie blue stained gel of 50 pg 
of liver proteins fractionated on 12% SDS-PAGE. For each dose of 
T3 + T4 administered. two different hver preparations are shown. 
Lanes 1.2 for 0 x dose; lanes 3.4 for 1 x dose and lanes 5.6 for 10 x 
dose. Molecular weight markers are shown m the left. Dashes on right 
side of the gel denote hver proteins that mcrease as a result of thyroid 
hormone treatment to the hypothyroid neonates. Lower panel. 50 pg 
of fractionated liver proteins were transferred to PVDF membranes 
and probed with affinity purified ant@-F,-ATPasc antibodies. Sam- 
ples are as indicated above. Migration of the /J subunit of the F,- 
ATPase complex is indicated by a closed arrowhead. (B) Autoradi- 
ogram (middle panel) of P-F,-ATPase end-labeled ohgonucleottde to 
30 pg of total liver RNA from one-hour-old hypothyroid neonates 
treated at birth with various T3 + T4 doses. For each dose of T3 + T4 
admuustered. two different RNA preparations are shown. Lanes 1.2 
for 0 x dose. lanes 3.4 for I x dose and lanes 5.6 for IO x dose. Above 
the autoradiogram a picture of a parallel ethidmm bromide-stained gel 
IS shown. I8 S and 38 S indicate the migration position of the corre- 
sponding ribosomal RNA bands. Lower panel. autoradiogram show- 
ing liver RNA hybridization signals to labeled human /J-actin cDNA 
Sample in lanes as Indicated above. (C) Autoradiograms of m vitro 
synthesized B-F,-ATPase and /?-actin mRNAs m isolated liver nuclei 
of hypothyroid rat neonates treated at birth with various thyroid 
hormone doses (lane 1.0 x dose; lane 2, 1 x dose and lane 3, 10 x dose) 
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scriptional level. To further analyze the mechanism by 
which thyroid hormones regulate P-F,-ATPase gene ex- 
pression, we have administered to hypothyroid neo- 
nates at the time of birth, various T3 + T4 doses (see 
section 2) and both the steady-state amounts of /3-F,- 
ATPase protein and mRNA were determined in their 
livers after 1 h of receiving the hormonal treatment (Fig. 
1). The doses (1 x and 10 x) of T3 + T4 administered 
were in the range of other in vivo studies of thyroid 
hormone effects in hypothyroid rats [ 11,12,18]. Usually, 
a pharmacological dosage (50-200 ,ug of T3/100 g body 
weight) is injected to promote saturation of nuclear re- 
ceptors. In our study, both moderate (1 x) and pharma- 
cological (10 x) administration of T3 + T4 to hypothy- 
roid neonates significantly increased the amount of the 
mitochondrial P-subunit of the F,-ATPase complex 
(Fig. lA, lower panel). In addition, the hormonal treat- 
ment promoted the appearance and/or increase in the 
relative amount of various selected liver polypeptides 
(most notorious are a 135 kDa, a 110 kDa and 56 kDa 
protein) (Fig. lA, upper panel). Similarly, both moder- 
ate (1 x) and pharmacological (10 x) doses of T3 + T4 
promoted a rapid increase in the steady-state amounts 
of /?-F,-ATPase mRNA in the liver of one-hour-old 
hypothyroid neonates (Fig. lB, middle panel). These 
results confirmed and extended our previous findings 
[5], revealing that administration at birth of thyroid 
hormones to hypothyroid neonates induced a rapid in- 
crease in liver /I-F,-ATPase protein and mRNA content 
(Table I). 
The rapid increase in liver mRNA levels for the p-F,- 
ATPase protein that occurs in T3 + T6treated hy- 
pothyroid neonates, could either result from an increase 
Table I 
Induction by thyroid hormones of&F,-ATPase protein. mRNA con- 
tent and transcrtptional rates of /3-F,-ATPase gene 
Parameter T3 + T4 dose 
ox lx 10 x 
j?-F,-ATPase protein (8) 1.0 + 0.1 (8) 2.0 2 O.l*** (8) 2.5 k O.l*** 
B-F,-ATPase mRNA (5) 1.0 2 0.1 (5) 1.8 ? O.l** (5) 2.2 k 0.3* 
Rates P-F,-ATPase 
transcription (5) 1.0 f 0 2 (4)2.0 L 0.2* (2) 3.1 IL 0.1** 
For details see legend to Fig. 1. Quantitatton (arbitrary units. a.u.) of 
j?-F,-ATPase protein and mRNA content m the hver of hypothyrotd 
neonates treated at birth wtth various T3 + T4 doses was carried out 
by laser densitometric scanning of the tmmunoreactive band or hy- 
bridizatton signal, respectively. Relative transcriptional rates were ex- 
pressed as arbitrary units of the values obtained from quantitation by 
densitometric scanning of the /?-F,-ATPaselB-actin hybridization stg- 
nals. The three parameters were relatively compared with those ob- 
tained in liver or isolated nuclei from non-T3 + T4-treated neonates 
(0 x dose). arbttrartly fixed to a value of 1. The results shown are 
means + S.E.M. The number of samples processed (liver proteins and 
mRNA levels) or expertments (transcnption) are indicated m paren- 
theses, *P < 0.01; **P < 0.0025 and ***P < 0.0005. when compared 
with 0 x dose, by Student’s t-test. 
in the rates of transcription for the p-F,-ATPase gene 
and/or from an increase in the stability of the cytoplas- 
mic mRNA, since both mechanisms for the expression 
of liver proteins are known to be controlled by thyroid 
hormones [11,12,14]. Hence, to answer the question if 
thyroid hormones affect transcriptional rates of the /?- 
F,-ATPase gene, we employed the in vitro approach of 
the nuclear ‘run-on’ assays using nuclei prepared from 
one-hour-old hypothyroid neonates treated at birth 
with various T3 + T4 doses. As shown in Fig. 1C and 
Table I, relative transcriptional rates of B-F,-ATPase 
gene (normalized to the /I-actin densitometric reading) 
were stimulated in a dose-dependent way by administra- 
tion of thyroid hormones to hypothyroid neonates. 
Comparison of fold-stimulation (over 0 x dose) in liver 
steady-state amounts of /?-F,-ATPase protein and 
mRNA after treatment of the neonates with the two 
thyroid hormone doses (Table I), revealed a similar 
fold-stimulation to that of ‘in vitro’ determined relative 
transcriptional rates for the 1 x dose and a slightly 
lower stimulation for the 10 x dose (Table I). This ap- 
parent discrepancy between liver steady-state P-F,- 
ATPase protein and mRNA levels with the in vitro 
determined transcriptional rates at high T3 + T4 dosage 
(10 x dose) (Table I) could reflect an unphysiological 
imbalance between transcriptional activation of the 
gene and post-transcriptional events involving the 
newly synthesized P-F,-ATPase mRNA precursor. In 
any case, the findings reported in this study most likely 
suggest that the increase in liver /?-F,-ATPase mRNA 
after thyroid hormones administration to hypothyroid 
neonates [5] is mainly due to the effect of the hormones 
in promoting transcriptional activation of the gene and 
thus, that negligible or no effect could be ascribed to a 
hormonal effect in the stability of liver /3-F,-ATPase 
mRNA. 
It has been shown that several nuclear-encoded 
‘housekeeping’ genes coding for mitochondrial proteins 
are regulated by thyroid hormones [5,18,26,2’7] and, in 
those cases in which the mechanism has been studied - 
cytochrome c [27] and P-F,-ATPase (this study) - this 
is as a result of transcriptional activation of the gene by 
thyroid hormones. Transcriptional activation of rat 
liver P-F,-ATPase gene by thyroid hormones (Fig. 1 
and Table I) could result from (i) a direct effect of the 
T3-receptor complex with short DNA sequence (cis- 
acting) elements located adjacent to the promoter or in 
enhancers of the gene and/or (ii) mediated through 
hormonal regulation of the activity of certain essential 
transcriptional factors (trans-acting) that could interact 
with the gene [28]. The existence of three putative TREs 
(Al, A2 and A3) has been described in the human B-F,- 
ATPase gene [5] in a DNA sequence region that has 
been shown to have certain promoter activity [28,29]. 
This might suggest that activation of rat liver /I-F,- 
ATPase gene transcription after thyroid hormone ad- 
ministration to hypothyroid neonates is the result of a 
111 
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direct interaction of the T3-receptor complex with any 
of these c&acting elements. However, the possiblity still 
exists, as reported for the expression of other thyroid 
hormone regulated genes [30-321, that thyroid 
hormones could affect the activity of certain trans-act- 
ing factor(s) involved in transcriptional activation of 
nuclear-encoded mitochondrial ‘housekeeping’ genes. 
In this regard, it is worth noting that thyroid hormones 
have been recently shown to affect the binding of tissue- 
specific and ubiquitous nuclear proteins to certain spe- 
cific DNA sequence elements located nearby (450 bp) 
the promoter of the human ATP synthase p subunit 
gene [33]. In conclusion, our findings indicate that acti- 
vation of /3-F,-ATPase gene transcription after thyroid 
hormones administration to hypothyroid neonates is 
the primary mechanism by which these neonates could 
rapidly promote differentiation of their liver mitochon- 
dria. 
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